Drug Profile
Research programme: histone deacetylase 6 inhibitors - Lycera
Alternative Names: HDAC6 inhibitors - LyceraLatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Lycera
- Class Small molecules
- Mechanism of Action HDAC6 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Autoimmune disorders
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Autoimmune-disorders in USA (PO)
- 19 Jul 2016 Early research in Autoimmune disorders in USA (PO)